GL1X · GenesisL1 explorer

Research workbench

Human adenosine kinase in complex with an acetylinic inhibitor

Analyse Human adenosine kinase in complex with an acetylinic inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2I6B
Type
protein
Length
655 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Adenosine kinase
UniProt
Q5VXR3
Ligands
89I
Pockets
3 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 36% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAdenosine kinaseprotein32936% helix, 22% strandQ5VXR3
BAdenosine kinaseprotein32637% helix, 20% strandQ5VXR3

Ligands and binding sites

  • 89I · 5-[4-(dimethylamino)phenyl]-6-[(6-morpholin-4-ylpyridin-3-yl)ethynyl]pyrimidin-4-amine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18700.750.798589I
28120.720.786989I
3590.280.7316empty

Compared structures

  • 2I6B · Human Adenosine Kinase in Complex with An Acetylinic Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.